Kuros Biosciences Logo

Kuros Biosciences

🇨🇭
KURN
CH0325814116

Kuros Biosciences, headquartered in Switzerland, is a leading biopharmaceutical company specializing in innovative bone graft substitutes. By developing advanced technologies for orthopedic surgery, Kuros Biosciences is dedicated to optimizing bone healing processes and patient outcomes worldwide.

Next Quarterly Earnings

Thursday, August 13, 2026
CW 33
Pre-Market
In 32 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on July 16, 2026

Stock Price

Frequently asked questions

When will Kuros Biosciences report its next quarterly earnings?

Kuros Biosciences is scheduled to report its next quarterly earnings on 08/13/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Kuros Biosciences last report quarterly earnings?

Kuros Biosciences last reported quarterly earnings on 4/14/2026 (Q2 2026).

How do I add the Kuros Biosciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:
Actual:
Q2 2026
Estimate:
Actual:
Price reaction (1 day):+2.9 %
Price reaction (7 days):-8.4 %
Q1 2026
Estimate:
Actual:CHF 0.05
Price reaction (1 day):+10.6 %
Price reaction (7 days):-12.3 %

Company Information

Name
Kuros Biosciences
Ticker Symbol
KURN
ISIN
CH0325814116
Country
🇨🇭
Switzerland
Sector
Healthcare